Clinical Trial Update: Impact of Intestinal Microbiota on Uremic Toxins Productions [NA]

View source ↗

Summary

A completed clinical trial investigated how the intestinal microbiota influences the production of uremic toxins in individuals with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Uremia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: CKD, Uremia | NA | Status: COMPLETED